This roundtable is part of the Chatham House High-Level Series on Cancer in collaboration with Merck Sharp & Dohme Corporation (MSD). It will bring together an international and diverse group of policymakers, academics, patient groups, and the private sector to share their perspectives, debate, and discuss lung cancer screening. The goal to is to explore approaches on lung cancer screening for future policy dialogs.
This is an invitation only event.
Participants
Chair: Robert Yates, Director, Global Health Programme; Executive Director, Centre for Universal Health, Chatham House.
